11/21
11:28 am
halo
Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock [Yahoo! Finance]
Low
Report
Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock [Yahoo! Finance]
11/20
10:24 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $68.00 price target on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $68.00 price target on the stock.
11/19
12:55 pm
halo
HALO vs. FOLD: Which Stock Should Value Investors Buy Now? [Yahoo! Finance]
Low
Report
HALO vs. FOLD: Which Stock Should Value Investors Buy Now? [Yahoo! Finance]
11/19
10:51 am
halo
Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now? [Yahoo! Finance]
Low
Report
Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now? [Yahoo! Finance]
11/19
10:51 am
halo
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? [Yahoo! Finance]
Low
Report
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? [Yahoo! Finance]
11/18
07:12 am
halo
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec [Yahoo! Finance]
Medium
Report
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec [Yahoo! Finance]
11/18
07:00 am
halo
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
Medium
Report
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
11/17
08:01 pm
halo
Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says [Yahoo! Finance]
Medium
Report
Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says [Yahoo! Finance]
11/15
11:54 am
halo
Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock [Yahoo! Finance]
Low
Report
Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock [Yahoo! Finance]
11/14
05:35 pm
halo
Germany's Evotec Gets Takeover Interest From Halozyme [Yahoo! Finance Canada]
High
Report
Germany's Evotec Gets Takeover Interest From Halozyme [Yahoo! Finance Canada]
11/14
04:27 pm
halo
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction [Yahoo! Finance]
High
Report
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction [Yahoo! Finance]
11/14
04:15 pm
halo
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
High
Report
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
11/14
03:55 pm
halo
Germany's Evotec Gets Takeover Interest From Halozyme [Yahoo! Finance]
Low
Report
Germany's Evotec Gets Takeover Interest From Halozyme [Yahoo! Finance]
11/8
09:58 am
halo
Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today [Yahoo! Finance]
Low
Report
Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today [Yahoo! Finance]
11/4
11:22 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at Piper Sandler from $51.00 to $52.00. They now have a "neutral" rating on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at Piper Sandler from $51.00 to $52.00. They now have a "neutral" rating on the stock.
11/3
08:04 am
halo
Results: Halozyme Therapeutics, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates [Yahoo! Finance]
Low
Report
Results: Halozyme Therapeutics, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates [Yahoo! Finance]
11/1
11:55 am
halo
HALO Beats Q3 Earnings & Sales Estimates, Raises '24 View, Stock Up [Yahoo! Finance]
Low
Report
HALO Beats Q3 Earnings & Sales Estimates, Raises '24 View, Stock Up [Yahoo! Finance]
11/1
09:40 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at JMP Securities from $72.00 to $73.00. They now have a "market outperform" rating on the stock.
Medium
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at JMP Securities from $72.00 to $73.00. They now have a "market outperform" rating on the stock.
11/1
08:15 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at HC Wainwright from $65.00 to $68.00. They now have a "buy" rating on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at HC Wainwright from $65.00 to $68.00. They now have a "buy" rating on the stock.
10/31
08:35 pm
halo
Halozyme Therapeutics (HALO) Reports Q3 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Low
Report
Halozyme Therapeutics (HALO) Reports Q3 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
10/31
04:01 pm
halo
HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Medium
Report
HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS
10/25
08:37 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $65.00 price target on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $65.00 price target on the stock.
10/24
06:30 am
halo
HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE
Medium
Report
HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE
10/23
04:30 pm
halo
Halozyme to Report Third Quarter 2024 Financial and Operating Results
Medium
Report
Halozyme to Report Third Quarter 2024 Financial and Operating Results
10/22
01:11 pm
halo
Halozyme Therapeutics: Behind The Pullback [Seeking Alpha]
Low
Report
Halozyme Therapeutics: Behind The Pullback [Seeking Alpha]